Webers CAB - Search Results

1

Retinal Functional and Structural Neural Indices: Potential Biomarkers for the Monitoring of Cerebral Neurodegeneration: The Maastricht Study.

van der Heide FCT, Mokhtar S, Khanna A, Said M, Henry RMA, Kroon AA, Dagnelie PC, Eussen SJPM, Berendschot TTJM, Schouten JSAG, Schram MT, van der Kallen CJH, van Greevenbroek MMJ, Wesselius A, Savelberg HHCM, Schaper NC, Webers CAB, Stehouwer CDA. van der Heide FCT, et al. Among authors: webers cab. J Alzheimers Dis. 2023;93(4):1471-1483. doi: 10.3233/JAD-230104. J Alzheimers Dis. 2023. PMID: 37182886 Free PMC article.

2

The impact of a nationwide introduction of new drugs and a treatment protocol for glaucoma on the number of glaucoma surgeries.

van der Valk R, Schouten JS, Webers CA, Beckers HJ, van Amelsvoort LG, Schouten HJ, Hendrikse F, Prins MH. van der Valk R, et al. J Glaucoma. 2005 Jun;14(3):239-42. doi: 10.1097/01.ijg.0000159121.11371.5f. J Glaucoma. 2005. PMID: 15870608

3

Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based review.

Olthoff CM, Schouten JS, van de Borne BW, Webers CA. Olthoff CM, et al. Ophthalmology. 2005 Jun;112(6):953-61. doi: 10.1016/j.ophtha.2004.12.035. Ophthalmology. 2005. PMID: 15885795 Review.

4

Intraocular pressure-lowering effects of all commonly used glaucoma drugs: a meta-analysis of randomized clinical trials.

van der Valk R, Webers CA, Schouten JS, Zeegers MP, Hendrikse F, Prins MH. van der Valk R, et al. Ophthalmology. 2005 Jul;112(7):1177-85. doi: 10.1016/j.ophtha.2005.01.042. Ophthalmology. 2005. PMID: 15921747

5

Socioeconomic differences in glaucoma patients' knowledge, need for information and expectations of treatments.

Hoevenaars JG, Schouten JS, van den Borne B, Beckers HJ, Webers CA. Hoevenaars JG, et al. Acta Ophthalmol Scand. 2006 Feb;84(1):84-91. doi: 10.1111/j.1600-0420.2005.00587.x. Acta Ophthalmol Scand. 2006. PMID: 16445444 Free article.

6

Changes in glaucoma treatment and achieved IOP after introduction of new glaucoma medication.

van der Valk R, Schouten JS, Webers CA, Hendrikse F, Prins MH. van der Valk R, et al. Graefes Arch Clin Exp Ophthalmol. 2006 Oct;244(10):1267-72. doi: 10.1007/s00417-005-0241-y. Epub 2006 Mar 17. Graefes Arch Clin Exp Ophthalmol. 2006. PMID: 16544116

7

Intraocular pressure-lowering effect of adding dorzolamide or latanoprost to timolol: a meta-analysis of randomized clinical trials.

Webers CA, van der Valk R, Schouten JS, Zeegers MP, Prins MH, Hendrikse F. Webers CA, et al. Ophthalmology. 2007 Jan;114(1):40-6. doi: 10.1016/j.ophtha.2006.07.018. Epub 2006 Oct 27. Ophthalmology. 2007. PMID: 17070584

8

Predicting intraocular pressure change before initiating therapy: timolol versus latanoprost.

van der Valk R, Webers CA, Hendrikse F, de Vogel SC, Prins MH, Schouten JS. van der Valk R, et al. Acta Ophthalmol. 2008 Jun;86(4):415-8. doi: 10.1111/j.1600-0420.2007.01065.x. Epub 2007 Nov 17. Acta Ophthalmol. 2008. PMID: 18028236 Free article. Clinical Trial.

9

Will improvement of knowledge lead to improvement of compliance with glaucoma medication?

Hoevenaars JG, Schouten JS, van den Borne B, Beckers HJ, Webers CA. Hoevenaars JG, et al. Acta Ophthalmol. 2008 Dec;86(8):849-55. doi: 10.1111/j.1755-3768.2007.01161.x. Epub 2008 May 26. Acta Ophthalmol. 2008. PMID: 18507734 Free article.

10

Side effects of commonly used glaucoma medications: comparison of tolerability, chance of discontinuation, and patient satisfaction.

Beckers HJ, Schouten JS, Webers CA, van der Valk R, Hendrikse F. Beckers HJ, et al. Graefes Arch Clin Exp Ophthalmol. 2008 Oct;246(10):1485-90. doi: 10.1007/s00417-008-0875-7. Epub 2008 Jun 25. Graefes Arch Clin Exp Ophthalmol. 2008. PMID: 18575878

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

194 results

Search Page